[Extension of survival period of breast cancer patients by a good 4 months].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001141:Aromatase / Q000627:therapeutic use*; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D018572:Disease-Free Survival; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D001141:Aromatase
Verlenging overlevingsduur borstkankerpatiënten met ruim vier maanden.